NATH vs. PCRX
NATH (Nathan's Famous, Inc.) and PCRX (Pacira BioSciences, Inc.) are both stocks. NATH operates in Restaurants (Consumer Cyclical), while PCRX operates in Drug Manufacturers - Specialty & Generic (Healthcare). Over the past 10 years, NATH returned 12.08%/yr vs -5.23%/yr for PCRX. At a 0.14 correlation, their price movements are largely independent.
Performance
NATH vs. PCRX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NATH achieves a 8.82% return, which is significantly higher than PCRX's -12.25% return. Over the past 10 years, NATH has outperformed PCRX with an annualized return of 12.08%, while PCRX has yielded a comparatively lower -5.23% annualized return.
NATH
- 1D
- -0.34%
- 1M
- 0.25%
- YTD
- 8.82%
- 6M
- 8.91%
- 1Y
- -3.25%
- 3Y*
- 13.33%
- 5Y*
- 10.93%
- 10Y*
- 12.08%
PCRX
- 1D
- 1.70%
- 1M
- -2.74%
- YTD
- -12.25%
- 6M
- -12.72%
- 1Y
- -6.27%
- 3Y*
- -17.24%
- 5Y*
- -17.77%
- 10Y*
- -5.23%
NATH vs. PCRX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NATH Nathan's Famous, Inc. | 8.82% | 24.58% | 3.51% | 19.24% | 18.67% | 8.05% | -20.24% | 8.66% | -11.19% | 23.77% |
PCRX Pacira BioSciences, Inc. | -12.25% | 37.37% | -44.16% | -12.61% | -35.83% | 0.55% | 32.10% | 5.30% | -5.76% | 41.33% |
Correlation
The correlation between NATH and PCRX is 0.22, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.22 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.18 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.16 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.15 |
Correlation (All Time) Calculated using the full available price history since Feb 3, 2011 | 0.14 |
Fundamentals
NATH:
$5.20
PCRX:
$0.21
NATH:
19.39
PCRX:
106.08
NATH:
2.64
PCRX:
1.34
NATH:
$157.78M
PCRX:
$734.86M
NATH:
$46.39M
PCRX:
$427.72M
NATH:
$33.87M
PCRX:
$95.04M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NATH vs. PCRX — Risk / Return Rank
NATH
PCRX
NATH vs. PCRX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Nathan's Famous, Inc. (NATH) and Pacira BioSciences, Inc. (PCRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NATH | PCRX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.05 | ||
| Sortino ratioReturn per unit of downside risk | -0.01 | ||
| Omega ratioGain probability vs. loss probability | 1.00 | 1.00 | 0.00 |
| Calmar ratioReturn relative to maximum drawdown | -0.17 | -0.21 | +0.05 |
| Martin ratioReturn relative to average drawdown | -0.30 | -0.45 | +0.16 |
Loading charts...
Drawdowns
NATH vs. PCRX - Drawdown Comparison
The maximum NATH drawdown since its inception was -76.16%, smaller than the maximum PCRX drawdown of -90.19%. Use the drawdown chart below to compare losses from any high point for NATH and PCRX.
Loading charts...
Drawdown Indicators
| NATH | PCRX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -76.16% | -90.19% | +14.03% |
Max Drawdown (1Y)Largest decline over 1 year | -19.52% | -29.61% | +10.09% |
Max Drawdown (3Y)Largest decline over 3 years | -21.67% | -70.82% | +49.15% |
Max Drawdown (5Y)Largest decline over 5 years | -35.27% | -85.67% | +50.40% |
Max Drawdown (10Y)Largest decline over 10 years | -53.17% | -85.67% | +32.50% |
Current DrawdownCurrent decline from peak | -8.82% | -80.96% | +72.14% |
Average DrawdownAverage peak-to-trough decline | -32.16% | -50.10% | +17.94% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 10.91% | 13.85% | -2.94% |
Volatility
NATH vs. PCRX - Volatility Comparison
The current volatility for Nathan's Famous, Inc. (NATH) is 1.36%, while Pacira BioSciences, Inc. (PCRX) has a volatility of 7.72%. This indicates that NATH experiences smaller price fluctuations and is considered to be less risky than PCRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NATH | PCRX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 1.36% | 7.72% | -6.36% |
Volatility (6M)Calculated over the trailing 6-month period | 10.59% | 28.43% | -17.84% |
Volatility (1Y)Calculated over the trailing 1-year period | 26.09% | 36.91% | -10.82% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 27.88% | 45.58% | -17.70% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 32.74% | 46.83% | -14.09% |
Dividends
NATH vs. PCRX - Dividend Comparison
NATH's dividend yield for the trailing twelve months is around 4.96%, while PCRX has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NATH Nathan's Famous, Inc. | 4.96% | 4.81% | 2.54% | 2.56% | 2.68% | 2.40% | 2.54% | 1.83% | 1.13% | 6.62% | 0.00% | 48.49% |
PCRX Pacira BioSciences, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
NATH vs. PCRX - Financials Comparison
This section allows you to compare key financial metrics between Nathan's Famous, Inc. and Pacira BioSciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
NATH vs. PCRX - Profitability Comparison
NATH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Nathan's Famous, Inc. reported a gross profit of 9.52M and revenue of 34.31M. Therefore, the gross margin over that period was 27.8%.
PCRX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Pacira BioSciences, Inc. reported a gross profit of 0.00 and revenue of 177.38M. Therefore, the gross margin over that period was 0.0%.
NATH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Nathan's Famous, Inc. reported an operating income of 5.13M and revenue of 34.31M, resulting in an operating margin of 14.9%.
PCRX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Pacira BioSciences, Inc. reported an operating income of 6.90M and revenue of 177.38M, resulting in an operating margin of 3.9%.
NATH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Nathan's Famous, Inc. reported a net income of 3.08M and revenue of 34.31M, resulting in a net margin of 9.0%.
PCRX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Pacira BioSciences, Inc. reported a net income of 7.08M and revenue of 177.38M, resulting in a net margin of 4.0%.
Frequently Asked Questions
NATH and PCRX have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
PCRX has higher volatility (7.72%) compared to NATH (1.36%). In terms of maximum drawdown, NATH dropped -76.16% vs PCRX's -90.19%.
NATH currently has the higher Sharpe Ratio (-0.13 vs -0.17), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NATH and PCRX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer